This photo provided by Novo Nordisk shows an injection pen of the company's drug Ozempic. On Tuesday, Dec. 5, 2017, the Food and Drug Administration approved the new, long-acting diabetes drug that reduces blood sugar levels and also helps people lose significant weight. (Novo Nordisk via AP)
Featured Photo Galleries
